Sierra Oncology's Series B Round

Sierra Oncology raised a round of funding on July 18, 2010.

Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for cancer and other diseases. The compa…

Articles about Sierra Oncology's Series B Round: